Igor D. Bandeira, MD, PhD
@igorbandeira
Brazilian physician-scientist and aspiring psychiatrist. Postdoctoral Research Fellow at Stanford University. Brain Stimulation. Ketamine. Psychedelics.
Thank you @apapsychiatric.bsky.social for highlighting our work in a press release at the APA Annual Meeting, and thank you @afspnational.bsky.social for supporting this research. Grateful to our Stanford team, especially co-first author Jason Tucciarone, mentor Alan Schatzberg, and collaborators
Levels of depressive symptoms did not differ between groups, suggesting that the effect was specific to suicidal ideation rather than overall depression severity. These findings indicate that low-dose buprenorphine represents a promising treatment approach for #suicideprevention.
50 participants with #depression and suicidal ideation received a single 0.5 mg/kg IV ketamine infusion over 40 min, followed by 4 weeks of low-dose buprenorphine (0.2–0.8 mg/day) or placebo. The buprenorphine group showed significantly greater reductions in suicidal ideation.
New publication! 🧠 Excited to share our latest paper, for which I am co-first author. This randomized controlled trial provides the first evidence that #buprenorphine can prolong and augment #ketamine’s antisuicidal effects in #depression. doi.org/10.1176/appi...
I’m very happy to share our new paper, recently published in iScience. Paper: doi.org/10.1016/j.is...
Loved attending the Brazil Global Health Initiative event yesterday at Stanford. Always inspiring to connect with brilliant Brazilian researchers doing amazing work across Silicon Valley. Proud to be part of this community! 🇧🇷
What an experience at #ACNP2026! Honored to present our Stanford randomized clinical trial demonstrating a novel strategy to sustain the antisuicidal effects of #ketamine in #depression as part of our mini-panel on buprenorphine and suicidality. @acnporg.bsky.social
Grateful to be back at #ACNP2026, supported by my Past Travel Awardee Funding! I'm a Stanford postdoc leading trials in interventional psychiatry with #BrainStimulation and #Ketamine for depression and suicide prevention. Join our mini-panel on 01/13 and poster on 01/15! @acnporg.bsky.social
Privileged our mini-panel was selected for #ACNP2026 @acnporg.bsky.social. Grateful to join Drs. J. John Mann (Columbia), Alan Schatzberg (Stanford), Mina Rizk (Mount Sinai) and Yunyu Xiao (Cornell). Looking forward to the discussions ahead!
Proud to receive the American College of Neuropsychopharmacology (ACNP) Past Travel Awardee Funding, recognizing my ongoing research progress. #ACNP2025 @acnporg.bsky.social
Spoke with @peerj.bsky.social about my research after receiving 1st Prize for Best Poster at the Winter Conference on Brain Research 2025. #WCBR2025 peerj.com/blog/post/11... Grateful for the chance to share what drives my work in interventional psychiatry.
Thrilled to share that our book chapter has just been published as part of #Bipolar Disorder: An Evidence-Based Clinical Guide (Springer Nature, 2025).
This recognition not only supports early-career researchers like myself, but also strengthens our collective mission to advance evidence-based care for depression and suicidality. #ADAA2025
I’m deeply grateful to the Anxiety and Depression Association of America (@adaaanxiety.bsky.social) for honoring me with the Alies Muskin Career Development Leadership Award this year. #ADAA2025
Happy to share that I have been selected for the Alies Muskin Career Development Leadership Award from the Anxiety and Depression Association of America (@adaaanxiety.bsky.social)! #ADAA2025
It was a great honor to receive the New Investigator Award and share the preliminary data from our @afspnational.bsky.social study at the 21st Annual Meeting of the International Society for CNS Clinical Trials and Methodology in Washington, DC. #ISCTM2025
Honored to have been selected for the New Investigator Award from the International Society for CNS Clinical Trials and Methodology! This recognition aligns with my passion for advancing rigorous and innovative research methodologies to improve psychiatric care. #ISCTM #ISCTM2025
I’m Still Here is a raw and unconventional exploration of identity, struggle, and reinvention. It reminds us that pain and adversity, rather than breaking us, can serve as catalysts for transformation.
Happy to be in beautiful Tahoe as a Travel Fellowship Awardee at the Winter Conference on Brain Research! If you're curious about interventional psychiatry, the opioid properties of #ketamine, and treatment-resistant #depression, stop by my poster tomorrow (Board #31)! #WinterBrain #WCBR2025
Feeling deeply grateful after an incredible #ACNP2024! It was an honor to connect with inspiring colleagues, foster new connections, and reunite with lifelong friends. Special thanks to the #TravelAward2024 program for the invaluable mentorship and support. @acnporg.bsky.social
Our poster T16 on #ketamine for suicidal behavior in treatment-resistant #depression is up now at #ACNP2024! Let's discuss the comparative analysis of antisuicidal and antidepressant effects!
Attending the recent panel on #suicideprevention at #ACNP2024 was truly thought-provoking. The dedication, innovative research, and shared commitment underscore the urgent need to advance effective interventions for this critical public health issue. @acnporg.bsky.social
Hey #ACNP2024! Grateful to return for my 2nd year, this time as a Travel Awardee! I’m a postdoc at Stanford, working on interventional psychiatry clinical trials with #BrainStimulation and #Ketamine for depression. Hope to see you at my poster (T16) on 12/10!
I am thrilled to announce that I have been honored with a Travel Fellowship Award to attend the 2025 Winter Conference on Brain Research!
Recruitment is ongoing for our study titled "Opiate Suicide Study in Patients with Major Depression" at Stanford University, sponsored by the American Foundation for Suicide Prevention.
Excited to share that our paper, demonstrating how early changes in lassitude can predict response to Stanford Neuromodulation Therapy in treatment-resistant depression, has been published in npj Mental Health Research, part of the @natureportfolio.bsky.social. www.nature.com/articles/s44...
Beyond happy to share that I am one of the recipients of the American College of Neuropsychopharmacology 2024 Travel Awards! Grateful to my mentors and colleagues who inspired me on this journey and provided valuable feedback on my application. #ACNP2024
Honored to announce that I've joined the editorial board of Springer Nature's BMC Psychiatry! Proud to support the dissemination of impactful research in mental health. bmcpsychiatry.biomedcentral.com/about/editor...